NICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drugPreviously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option Share XNICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drughttps://pharmaphorum.com/news/nice-okays-roche-liver-cancer-immunotherapy-sanofis-rare-disease-drug/
Sanofi’s rare disease drug Cablivi approved in the EUThe European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired Share XSanofi’s rare disease drug Cablivi approved in the EUhttps://pharmaphorum.com/news/sanofi-cablivi-approved-europe/
After more encouraging data, Ablynx to file first drug with FDANew trial data will be included in US and EU filings Share XAfter more encouraging data, Ablynx to file first drug with FDAhttps://pharmaphorum.com/news/ablynx-prepares-us-filing-caplacizumab-attp/